Trial Profile
Study Title: A Phase 4 Study to Assess the Clinical Efficacy of H.P. Acthar Gel 80 U/ml to Improve the Signs and Symptoms in Subjects With Dry Eye Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Apr 2022
Price :
$35
*
At a glance
- Drugs Corticotropin (Primary)
- Indications Dry eyes
- Focus Adverse reactions; Therapeutic Use
- 23 Apr 2022 Primary endpoint (1. Conjunctival Staining With Lissamine Green) has been met, according to Results published in the Ophthalmology and Therapy.
- 23 Apr 2022 Primary endpoint (Dry Eye Comfort Questionnaire, SANDE) has been met, according to Results published in the Ophthalmology and Therapy.
- 23 Apr 2022 Results published in the Ophthalmology and Therapy